This article was last updated on April 16, 2022
Canada: 
Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
Amid growing concerns regarding patients travelling abroad for unproven treatments of multiple sclerosis, director of the multiple sclerosis research unit at The Ottawa Hospital, Dr. Mark S. Freedman, has announced to begin the clinical trials of stem cell therapy. The Canadian trials which are funded by a $4.2-million grant from the Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation.
In his remarks, Dr. Freedman stated that “this is the first major stem cell trial that is going on in MS right now around the world” adding that “there is so much noise about stem cells in general and the hype that surrounds them, we are doing this study properly so we can answer the question for once and for all.” Recent reports alleging that hockey legend, Gordie Howe, had a risky stem cell treatment in Mexico after having a stroke has focused attention on a growing international stem cell tourism industry offering therapies that have not been approved for use in Canada or the United States.
According to Freedman, he is saddened to see patients travelling abroad to try risky and expensive treatments out of desperation. He alleged that these foreign clinics are preying on patients’ desperation by providing treatment that is not properly tested or proven to do any good. More importantly, he stressed that they could carry serious risks. Freedman alleged that this is the main reason we are conducting the clinical trials.
Be the first to comment